Publications by authors named "Daniel Krell"

Claim this Profile
M
Mixed Neuroendocrine and Non-neuroendocrine Tumor of Pancreato-Biliary Origin Treated Successfully with Peptide Receptor Radionuclide Therapy.
Kalyan Mansukhbhai Shekhda, Tu Vinh Luong, Daniel Krell, Shaunak Navalkissoor, Anna Paterson

J Gastrointest Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
Benjamin R Challoner, Andrew Woolston, David Lau, Marta Buzzetti, Caroline Fong, Daniel Krell

J Pathol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
Mairéad G McNamara, Jayne Swain, Zoe Craig, Rohini Sharma, Olusola Faluyi, Daniel Krell

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours.
Aimee R Hayes, Tu Vinh Luong, Jamie Banks, Heer Shah, Jennifer Watkins, Daniel Krell

J Neuroendocrinol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis.
Aimee R Hayes, Myles Furnace, Ruchir Shah, Caroline Rundell, Gregory Muller, Daniel Krell

Pancreas· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Francesca M Rizzo, Clare Vesely, Alexa Childs, Teresa Marafioti, Mohid S Khan, Daniel Krell

Br J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
Nicholas Brown, Catherine McBain, Stephen Nash, Kirsten Hopkins, Paul Sanghera, Daniel Krell

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer.
Daniel Krell, Fran Said Battistino, Sarah Benafif, Lochani Ganegoda, Marcia Hall

Int J Gynecol Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Idh1 in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis.
Chiara Bardella, Osama Al-Dalahmah, Daniel Krell, Pijus Brazauskas, Khalid Al-Qahtani

Cancer Cell· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.
Adam E Frampton, Jonathan Krell, Nigel B Jamieson, Tamara M H Gall, Elisa Giovannetti, Daniel Krell

Eur J Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutation screening in human glioblastomas.
Daniel Krell, Paul Mulholland, Justin Stebbing, Ian Tomlinson, Chiara Bardella

Future Sci OA· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
Daniel Krell, Paul Mulholland, Adam E Frampton, Jonathan Krell, Justin Stebbing

Future Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aristolochia: the malignant truth.
Daniel Krell, Justin Stebbing

Lancet Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathways.
Adam E Frampton, Jonathan Krell, Elisa Giovannetti, Daniel Krell, Justin Stebbing

Expert Rev Anticancer Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
Daniel Krell, Mawuelikem Assoku, Malcolm Galloway, Paul Mulholland, Ian Tomlinson

PLoS One· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis